Volatility Spikes: Middle East Conflict Shakes Global Markets
Oil and geopolitics are rewriting market direction, creating sharp divergences across traditional and crypto assets.
Read MoreThe Ouinex Blog.
Company announcements, market analysis, trading tips and head-to-head exchange comparisons.
Global Markets Retreat as Oil and Gold Surge
Markets are reeling as geopolitical shocks push oil and safe assets higher and equities lower.
Read More
The VIP Weekly Recap
Week of February 23–28, 2026 · 109 shared plans · 7 active coaches · 8 trading rooms · 100% transparency While you were hesitating to join us, our members were getting real results. Execution, strategy, massive performance, and above all, uncompromising risk management. Monday through Friday. The Week in Numbers
Read More
Macro & Micro Financial Agenda – Week of March 1 to 6
Sunday, March 1 – OPEC+ Strategy Meeting and Chinese Indicators OPEC+: Decision on April Oil Production Eight key OPEC+ countries hold their monthly meeting to decide production quotas for April. Potential direct impact on oil prices, energy stocks, and inflation. Chinese Electric Vehicles: Delivery Figures Monthly publications from: Nio (NIO)
Read More
War, Markets, and Risk: What the Escalation in Iran Means for Your Portfolio
Geopolitical risk is pushing markets into volatility today.
Read More
Tech Momentum and Trade Realities Drive Global Markets
Global stock indices are surging on a wave of artificial intelligence optimism and shifting trade dynamics.
Read More
US PREMARKET: The Briefing for February 24, 2026
US indices are advancing this Tuesday morning, attempting to stabilize the market after Monday’s AI-related sector selloff. While the macroeconomic landscape is marked by the implementation of new tariffs, it’s the announcement of a monumental deal between AMD and Meta that is driving the tech trend. Market Status (Premarket) Wall
Read More
100% French Stocks – February 24, 2026
PREOPEN CAC 40: 8,503 points (+0.05%) Key Actions of the Day EDENRED (EDEN): The employee benefits specialist confirmed it expects an organic decline in its EBITDA in 2026 due to changes in the regulatory framework in Brazil and Italy. Despite better-than-expected results for 2025, this announcement weighs on medium-term prospects.
Read MoreUS Premarket: Index Tension and Pharma Showdown
Futures Performance Dow Jones: -0.44% S&P 500: -0.39% Nasdaq 100: -0.56% Top Gainers Vanda Pharmaceuticals (+33%): Massive surge after FDA approves Bysanti for schizophrenia and bipolar disorders. Veris Residential (+13.3%): Buyout confirmed by Affinius Capital at $19 per share, representing a 23.2% premium over the February 4th closing price. Eli
Read More